drugset / Trial / NCT00023946

BMS-247550 in Treating Patients With Liver or Gallbladder Cancer

NCT00023946

Phase 2 Terminated 50 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase II trial to study the effectiveness of BMS-247550 in treating patients who have liver or gallbladder cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start
2001-08
Primary completion
2005-07
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixabepilone Small molecule Intravenous